Viewing Study NCT03912818


Ignite Creation Date: 2025-12-25 @ 4:59 AM
Ignite Modification Date: 2025-12-26 @ 3:59 AM
Study NCT ID: NCT03912818
Status: TERMINATED
Last Update Posted: 2023-09-11
First Post: 2019-04-08
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer
Sponsor: Stanford University
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: IRB-48062
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View